# Iron Horse Acquisition II Corp.: financial statements, quarterly

IRHO · Nasdaq · CIK 2051985 · [Industrials](/sectors/industrials.md) · fiscal year ends Nov 30

Pages: [Overview](/companies/irho.md) · [Financials](/companies/irho/financials.md) · [Filings](/companies/irho/filings.md) · [Insiders](/companies/irho/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/irho/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-02-28) | period not labelled (2025-05-31) | period not labelled (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $k | [(72.7)](/filings/0001213900-26-039388.md) | [(23.2)](/filings/0001213900-26-077587.md) | [(71.5)](/filings/0001213900-26-108511.md) | [(37.1) d](/filings/0001213900-26-015865.md) | [(278)](/filings/0001213900-26-039388.md) | [(773)](/filings/0001213900-26-077587.md) | [(233)](/filings/0001213900-26-108511.md) |
| Net income | $k | [(72.7)](/filings/0001213900-26-108511.md) | [(23.2)](/filings/0001213900-26-108511.md) | [(71.5)](/filings/0001213900-26-108511.md) | [(37.1) d](/filings/0001213900-26-015865.md) | [1,359](/filings/0001213900-26-108511.md) | [1,301](/filings/0001213900-26-108511.md) | [1,876](/filings/0001213900-26-108511.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2024-11-30) | period not labelled (2025-02-28) | period not labelled (2025-05-31) | period not labelled (2025-08-31) | FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-26-108511.md) | [0.7](/filings/0001213900-26-039388.md) | [0.0](/filings/0001213900-26-077587.md) | [0.0](/filings/0001213900-26-108511.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001213900-26-108511.md) | [0.9](/filings/0001213900-26-039388.md) | [0.4](/filings/0001213900-26-077587.md) | [0.4](/filings/0001213900-26-108511.md) |
| Total assets | $m | [0.0](/filings/0001213900-26-015865.md) | not reported | not reported | not reported | [0.4](/filings/0001213900-26-108511.md) | [232](/filings/0001213900-26-039388.md) | [234](/filings/0001213900-26-077587.md) | [236](/filings/0001213900-26-108511.md) |
| Current liabilities | $m | [0.0](/filings/0001213900-26-015865.md) | not reported | not reported | not reported | [0.5](/filings/0001213900-26-108511.md) | [0.2](/filings/0001213900-26-039388.md) | [0.2](/filings/0001213900-26-077587.md) | [0.2](/filings/0001213900-26-108511.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | [0.5](/filings/0001213900-26-108511.md) | [11.1](/filings/0001213900-26-039388.md) | [11.4](/filings/0001213900-26-077587.md) | [11.6](/filings/0001213900-26-108511.md) |
| Shareholders' equity | $m | [(0.0)](/filings/0001213900-26-108511.md) | [(0.0)](/filings/0001213900-26-108511.md) | [(0.1)](/filings/0001213900-26-108511.md) | [(0.1)](/filings/0001213900-26-108511.md) | [(0.2)](/filings/0001213900-26-108511.md) | [(10.2)](/filings/0001213900-26-108511.md) | [(10.9)](/filings/0001213900-26-108511.md) | [(11.2)](/filings/0001213900-26-108511.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2025-02-28) | period not labelled (2025-05-31) | period not labelled (2025-08-31) | Q4 FY2025 (2025-11-30) | Q1 FY2026 (2026-02-28) | Q2 FY2026 (2026-05-31) | Q3 FY2026 (2026-08-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(51.5)](/filings/0001213900-26-039388.md) | [(20.6) d](/filings/0001213900-26-077587.md) | [(42.9) d](/filings/0001213900-26-108511.md) | [(27.8) d](/filings/0001213900-26-015865.md) | [(473)](/filings/0001213900-26-039388.md) | [(671) d](/filings/0001213900-26-077587.md) | [210 d](/filings/0001213900-26-108511.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 29,320,000 at 2026-10-09, from the cover of the [10-Q filed 2026-10-09](/filings/0001213900-26-108511.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.